Endocrinology · 1974 · 48 citations · 0 references
MedicineEndocrinologyPharmacologyHormone BiochemistryNeuroendocrinologyNeuropharmacologyHormone ReleaseHormone SecretionHypothalamic-pituitary RegulationPituitary Gland FunctionPituitary Hormone RegulationPituitary HormonesDopamine Inhibition Of ProlactinDopamine-mediated InhibitionHypothalamic HormonesHypothalamic Regulation Of ProlactinHypothalamic-pituitary-prolactin AxisHypothalamic-releasing HormonesProlactin Secretion RegulationReleasing Hormones
Rat anterior hemipituitaries were incubated in Krebs-Ringer bicarbonate containing 3H-leucine. Both newly synthesized 3H-prolactin (PRL) and radioimmunoassayable PRL released into the medium during a 6-hr incubation were assayed. Dopamine (DA) at 5 × 10−7M and 2 × 10−7M inhibited 97‰ and 92‰, respectively, of 3H-PRL release as compared to release in the absence of DA. Respective inhibition values for radioimmunoassayable PRL release were 75‰ and 53‰ The addition of thyrotropin-releasing hormone (TRH) at 25 ng⁄ml partially blocked the catecholamine effect. DA at 5 × 10−7M and 2 × 10−7M inhibited 80‰ and 48‰, respectively, of 3H-PRL release, and 41‰ and 24‰ of radioimmunoassayable PRL release. DA at 7.5 × 10−8M inhibited 3H-PRL and radioimmunoassayable PRL release 78‰ and 57‰, respectively. The addition of TRH (5 ng⁄ml) almost completely prevented the DA effect with both 3H-PRL and radioimmunoassayable PRL release remaining at 90‰ of levels seen in the absence of DA. These data are consistent with DA and TRH having, respectively, properties of prolactin inhibiting and prolactin releasing factors. (Endocrinology95:1189, 1974)